Could a lower dose of Post-Transplant drug be safer for older blood cancer patients?
Disease control
Recruiting now
This study is for people aged 65 and older with blood cancers who are getting a stem cell transplant. Researchers want to find the safest lowest dose of a drug called cyclophosphamide, which is given after transplant to prevent the immune system from attacking the body. The goal …
Phase: PHASE1 • Sponsor: Ronald Paquette • Aim: Disease control
Last updated May 17, 2026 02:06 UTC